272 related articles for article (PubMed ID: 31489798)
1. Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases.
Jia ET; Liu ZY; Pan M; Lu JF; Ge QY
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):781-792. PubMed ID: 31489798
[TBL] [Abstract][Full Text] [Related]
2. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
3. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor promotes healthy microbial metabolites and microbiome.
Chatterjee I; Lu R; Zhang Y; Zhang J; Dai Y; Xia Y; Sun J
Sci Rep; 2020 Apr; 10(1):7340. PubMed ID: 32355205
[TBL] [Abstract][Full Text] [Related]
5. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
Jia W; Xie G; Jia W
Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):111-128. PubMed ID: 29018272
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling.
Wang Q; Lin H; Shen C; Zhang M; Wang X; Yuan M; Yuan M; Jia S; Cao Z; Wu C; Chen B; Gao A; Bi Y; Ning G; Wang W; Wang J; Liu R
Gut Microbes; 2023 Dec; 15(2):2274124. PubMed ID: 37942583
[TBL] [Abstract][Full Text] [Related]
7. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
8. Bile-ology: from bench to bedside.
Jin LH; Fang ZP; Fan MJ; Huang WD
J Zhejiang Univ Sci B; 2019 May; 20(5):414-427. PubMed ID: 31090267
[TBL] [Abstract][Full Text] [Related]
9. Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment.
Zhang Y; Gao X; Gao S; Liu Y; Wang W; Feng Y; Pei L; Sun Z; Liu L; Wang C
Immunology; 2023 Nov; 170(3):301-318. PubMed ID: 37317655
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?
Baptissart M; Vega A; Martinot E; Baron S; Lobaccaro JM; Volle DH
Cell Mol Life Sci; 2013 Dec; 70(23):4511-26. PubMed ID: 23784309
[TBL] [Abstract][Full Text] [Related]
11. Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far.
Zhu Z; Xu Y; Xia Y; Jia X; Chen Y; Liu Y; Zhang L; Chai H; Sun L
Life Sci; 2024 Jan; 336():122304. PubMed ID: 38016578
[TBL] [Abstract][Full Text] [Related]
12. The bile-gut axis and metabolic consequences of cholecystectomy.
Lange AH; Pedersen MG; Ellegaard AM; Nerild HH; Brønden A; Sonne DP; Knop FK
Eur J Endocrinol; 2024 Mar; 190(4):R1-R9. PubMed ID: 38551177
[TBL] [Abstract][Full Text] [Related]
13. Interaction of gut microbiota with bile acid metabolism and its influence on disease states.
Staley C; Weingarden AR; Khoruts A; Sadowsky MJ
Appl Microbiol Biotechnol; 2017 Jan; 101(1):47-64. PubMed ID: 27888332
[TBL] [Abstract][Full Text] [Related]
14. Bile acid signalling and its role in anxiety disorders.
Chen S; Shao Q; Chen J; Lv X; Ji J; Liu Y; Song Y
Front Endocrinol (Lausanne); 2023; 14():1268865. PubMed ID: 38075046
[TBL] [Abstract][Full Text] [Related]
15. Bile Acid Signaling in Inflammatory Bowel Disease.
Bromke MA; Krzystek-Korpacka M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445800
[TBL] [Abstract][Full Text] [Related]
16. Bile Acid Signaling in Neurodegenerative and Neurological Disorders.
Grant SM; DeMorrow S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825239
[TBL] [Abstract][Full Text] [Related]
17. Bile Acids in the Treatment of Cardiometabolic Diseases.
Vítek L
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s43-s52. PubMed ID: 29080341
[TBL] [Abstract][Full Text] [Related]
18. The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease.
Li Z; Yuan H; Chu H; Yang L
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630619
[TBL] [Abstract][Full Text] [Related]
19. Bile acids and the gut microbiota: metabolic interactions and impacts on disease.
Collins SL; Stine JG; Bisanz JE; Okafor CD; Patterson AD
Nat Rev Microbiol; 2023 Apr; 21(4):236-247. PubMed ID: 36253479
[TBL] [Abstract][Full Text] [Related]
20. Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.
Sipe LM; Chaib M; Pingili AK; Pierre JF; Makowski L
Immunol Rev; 2020 May; 295(1):220-239. PubMed ID: 32320071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
